HIV-infected patients aged above 75 years
Background.Little data is available on HIV-infected patients aged over 75 years. Methods.A descriptive study of HIV-infected patients aged over 75 years was conducted in six hospitals of the Pays de la Loire region, France. Socio-demographic, immuno-virological, and therapeutic characteristics were...
Gespeichert in:
Veröffentlicht in: | Médecine et maladies infectieuses 2020-02, Vol.50 (1), p.43-48 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background.Little data is available on HIV-infected patients aged over 75 years. Methods.A descriptive study of HIV-infected patients aged over 75 years was conducted in six hospitals of the Pays de la Loire region, France. Socio-demographic, immuno-virological, and therapeutic characteristics were collected via an electronic medical record software (Nadis®). To assess frailty, a simplified geriatric assessment was conducted during an HIV routine visit. Results.Among the 3965 patients followed in the six centers, 65 (1.6%) were aged over 75 years. From January to May 2016, 51 patients were included in the study: median age 78.7 years, male patients 74.5%, homosexual transmission 41.2%, living at home 98% and single in 54.5% of cases, median duration of HIV infection 18.8 years, median CD4 nadir 181 cells/mm3; CDC stage C 36.4%. All patients were on antiretroviral therapy and 98% of them had an HIV RNA < 50 c/mL; 82% of patients had at least one comorbidity and 58% at least two comorbidities. Eleven of 51 patients (21.6%) were diagnosed as at risk of frailty and 2/51 (3.9%) were considered frail. Cognitive disorders were diagnosed in 60.8%, depression in 35.3%, malnutrition in 25.5%, and vitamin D deficiency in 45.9%. Conclusions.HIV-infected patients aged above 75 years are well-managed, but the prevalence of geriatric comorbidities is high. |
---|---|
ISSN: | 0399-077X 1769-6690 |
DOI: | 10.1016/j.medmal.2019.04.001 |